Newborn Babies Born Addicted To Drugs Experience Withdrawals

On your average day, in the United States, there are around 10,650 babies born, give or take.  Unfortunately though it is said that the number of babies born addicted to prescription painkillers and psychiatric drugs is growing at an alarming rate, and the babies are suffering some detrimental consequences due to neonatal drug withdrawal.

Neonatal drug withdrawal occurs when a baby who has been exposed to drugs in the womb develops withdrawal symptoms. This occurs because the baby is no longer exposed to the drug the mother was taking. This condition can be caused by medicines, alcohol, and illegal drugs. It can take weeks to months for a baby to fully withdraw from a drug. Without treatment, this can be a life-threatening condition.

According to an April 2011 article in Psychiatry Online babies born to women with psychotic disorders often have the deck stacked against them.  Their mothers tend to receive less prenatal care; have poorer nutrition; use more tobacco, alcohol, and illicit drugs; are unlikely to be married; and often have limited social support. New labeling recently promulgated by the Food and Drug Administration (FDA) warns that these babies may also be susceptible to withdrawal symptoms from their mothers’ antipsychotic medications, but some practitioners fear the results of those warnings will be worse than the symptoms of withdrawal.

Early in 2011, the FDA posted a Safety Alert for Human Medical Products notifying health care professionals that the pregnancy section of drug labels for the entire class of antipsychotic drugs was updated. The new drug labels contain more and consistent information about the potential risk for extrapyramidal symptoms (EPS) and withdrawal symptoms in newborns whose mothers were treated with antipsychotic medications during the third trimester of pregnancy. Drugs that received the warning included: Haldol, FazaClo, Fanapt, Clozaril, Risperdal, Zyprexa, Seroquel, Abilify, Geodon, Invega, Loxitane, Moban, Navane, Orap, Saphris, Stelazine, Thorazine, and the olanzapine-fluoxetine combination known as Symbyax and are primarily used in the treatment of schizophrenia and bipolar disorder.

The symptoms of EPS and withdrawal in newborns may include agitation, abnormally increased or decreased muscle tone, tremor, sleepiness, severe difficulty breathing, and difficulty in feeding. In some newborns, the symptoms subside within hours or days and do not require specific treatment; other newborns may require longer hospital stays.

According to the FDA, the update was prompted by a search of the FDA’s Adverse Event Reporting System database through October 29, 2008, which identified 69 cases of neonatal EPS or withdrawal with all antipsychotic drugs.

“Symptoms reported included agitation, hypertonia, hypotonia, tremor, somnolence, respiratory distress, and feeding disorder,” according to the Safety Alert. “Blood levels were not provided, making it not possible to determine whether the events resulted from antipsychotic drug toxicity or withdrawal. Some cases described the time at which the onset of symptoms occurred, and they ranged from birth to one month after birth. The symptoms varied in severity; some neonates recovered within hours or days without specific treatment, while others required intensive care unit support and prolonged hospitalization.  Medications used to treat a suspected withdrawal reaction in the neonates included phenobarbital and benzodiazepines.”

 



, , , , , , ,

No comments yet.

Leave a Reply

GET HELP NOW!
  • This field is for validation purposes and should be left unchanged.
Latest Drug Injury News

What Is Doribax?

According to the FDA the antibacterial drug Doribax, that has been used to treat patients who develop pneumonia on ventilators, carries an increased risk of death and has a lower clinical cure rate by injection compared a similar drug known as Primaxin. What is Doribax? Doribax is an antibiotic that fights serious infections caused by […]

Is Using Tylenol or Ibuprofen During Pregnancy linked to ADHD?

What is a mother to do if she becomes ill during pregnancy?  The risks of consuming common drugs when pregnant are complex.  Although many doctors assure mothers that taking Tylenol is safe, a recent study by JAMA Pediatrics suggests otherwise.  The study found that mothers who used Tylenol for fever reduction while pregnant reported greater […]

Paxil Linked To Breast Cancer

City of Hope Cancer researchers indicate that a new test called the AroER Tri-Screen, desgined to look for drug side effects that could cause cancer, found a potential link between Paxil and breast cancer.  Paxil is a widely prescribed anti depressant. Research Researchers have found that Paxil has a weak estrogen effect that could increase […]

What Is Stroke?

Have you or someone you know had a stroke?  Chances are…yes.  According to the CDC, stroke is the fourth leading cause of death in the United States. About 800,000 people in the U.S. have a stroke each year. What Is Stroke? Stroke occurs when a blood clot blocks an artery or a blood vessel breaks, […]

Paxil Possibly Linked To Breast Cancer Risk

Cancer researchers from the City of Hope National Medical Center announced a possible link between Paxil and breast cancer. Research focused on Paxil’s estrogen effect Researchers found that Paxil has a weak estrogen effect that could increase women’s breast cancer risks. According to lead author and chairman of City of Hope’s Department of Cancer and […]

Latest Medical Device Injury News

Report Raises Concerns Over Heart Defibrillator Leads

The Food and Drug Administration (FDA) has just announced that they received a report that a St. Jude Durata cardiac defibrillator lead conductor became externalized; meaning the wire carrying electricity from the heart defibrillator to the heart was exposed through its insulation, a potentially dangerous and life-threatening defect.

HeartSine Class 1 Defibrillator Recall

HeartSine sent out a letter to customers in September, warning that the defibrillators may intermittently turn on and off, eventually depleting the battery.

FDA Medical Device Approval Based On Little Evidence

More than half of the high-risk cardiovascular devices approved in the past decade had no supporting active control data.

St. Jude Medical Gets FDA Warning

St. Jude Medical Inc. said it received a FDA warning about manufacturing and quality-control problems at its Sylmar, California, plant.

Hospira Still Facing Manufacturing And Regulatory Issues

Hospira has sent out 11 device notifications so far in 2013, including recall and device corrections. The company also said it sent notices to customers about some of its infusion pumps that had to either be recalled, fixed or adjusted.